PRESS-RELEASE ·Filed Jul 21, 2026
Press release · M&A
Actionable Insight • Neutral
This is a routine conference participation announcement with no trading catalyst. Monitor for future pipeline updates or regulatory milestones regarding Rezolute's HI program.
Final — all horizons settled through T+60d
RZLT ▼ -9.43% at T+60d
NEUTRAL call -9.43% · α vs SPY -13.40% · entry $5.09 → $4.61
T+1d
-1.77%
call -1.77% · α -1.65%
$5.00
settled 3mo ago
T+5d
-2.95%
call -2.95% · α -1.72%
$4.94
settled 3mo ago
T+20d
-8.45%
call -8.45% · α -11.01%
$4.66
settled 2mo ago
T+60d
-9.43%
call -9.43% · α -13.40%
$4.61
settled 13d ago
Price Chart
Loading chart...
Executive Summary
Rezolute announced management participation in the BTIG Virtual Biotechnology Conference on July 28-29, 2026. This is a routine investor relations event with no material financial or operational news disclosed. The filing provides no new data on pipeline, financials, or regulatory milestones.
Key Facts
- Rezolute management will participate in the BTIG Virtual Biotechnology Conference on July 28-29, 2026.
- No financial results, guidance, or pipeline updates were disclosed in the press release.
- The company is a late-stage ultra-rare disease company focused on treating refractory hypoglycemia caused by hyperinsulinism (HI).
Financial Impact
No financial impact disclosed.
Risk Factors
- No new information to assess risks; pipeline and regulatory risks remain unchanged.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (16 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3330330 |
13 reports for RZLT
80% Hit rate @ T+20 Went positive at some point 5 of 5 best @ T+60▲ +26.00%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | DEF 14A | $3.86 | awaiting T+20 | — | $3.82 (−1.04%) |
Oct 14, 2026 12d ago | 8-K | $3.90 | awaiting T+20 | — | $3.82 (−2.05%) |
Oct 5, 2026 21d ago | 8-K | $4.33 | awaiting T+20 | — | $3.82 (−11.78%) |
Sep 24, 2026 4w ago | 8-K | $3.90 $3.86 | ▲ +1.15% | ▼ −0.32% | $3.82 (+2.05%) |
Sep 24, 2026 4w ago | Press Release | $3.90 $3.86 | ▲ +1.15% | ▼ −0.32% | $3.82 (+2.05%) |
Jul 21, 2026 13w ago | Press Release | $5.09 $4.66 | ▼ −8.45% | ▼ −11.01% | $3.82 (−24.95%) |
Jun 11, 2026 19w ago | Institutional Cluster | $3.86 $5.13 | ▲ +32.90% | ▲ +31.01% | $3.82 (−1.04%) |
Jun 4, 2026 20w ago | Press Release | $4.51 $4.91 | ▲ +8.87% | ▲ +10.24% | $3.82 (−15.30%) |
Jun 2, 2026 20w ago | 8-K | $4.00 $4.95 | ▲ +23.75% | ▲ +25.32% | $3.82 (−4.50%) |
May 12, 2026 23w ago | 8-K | $3.33 $3.86 | ▲ +15.92% | ▲ +16.53% | $3.82 (+14.71%) |
Showing 10 of 13
US Market Status
Market Closed — Opens Wed (11h 57m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers